I think no one wants to take the risk until there is a major establishment player backing it. India is the second country to approve a MAB for Covid. Cuba was actually first. Our country doesn't trust Cuba, but they trust India. My hope is that the Indian seal of approval will actually open the door for us. Leronlimab has a different MOA than itolizumab, but as I understand it, they accomplish the same thing. I have hopes that the attention itolizumab is now getting will actually help us. Prayers for the M2M data.